Zama has expanded its confidential finance offerings on Ethereum by launching 16 new Morpho vaults for assets like USDC, USDT, AUSD, and TGBP, including encrypted versions. These vaults enable institutions and traders to earn yield onchain without revealing their positions or strategies, addressing privacy concerns on public blockchains. Alongside this, Zama introduced a private swap protocol allowing confidential exchanges between vault shares and tokens without public disclosure. This development aims to attract institutional users seeking privacy while maintaining the benefits of Ethereum's public settlement layer. Future integrations with wallets like Zerion and Yield.xyz are planned to broaden access.
Zama's expansion of confidential Morpho vaults and private swaps on Ethereum comes as a backdrop to the broader cryptocurrency market on Pluang. For readers following crypto assets, here is Pluang's market snapshot as of Sep 15, 2026 23:51 WIB: out of 50 major cryptocurrencies, 8 rose while 41 fell. Ethereum (ETH) traded at Rp42.844.587 with a 1-day change of -3.93% and a typical hold time of 106 days, contrasting with Cardano (ADA) at Rp3.570, down 4.08%, and Zilliqa (ZIL) at Rp50, down 4.05%. Pluang order activity shows Ethereum buyers at 60%, while Zilliqa sellers dominate at 77%.
Uber Technologies reported a 25% year-over-year increase in gross bookings to $53.7 billion in Q1 2026, driven by growth in ride-hailing, delivery, grocery, retail, and membership services. CEO Dara Khosrowshahi's recent purchase of 141,000 shares wo...
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
